174 related articles for article (PubMed ID: 18237109)
1. Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.
Vivier M; Rapp M; Papon J; Labarre P; Galmier MJ; Sauzière J; Madelmont JC
J Med Chem; 2008 Feb; 51(4):1043-7. PubMed ID: 18237109
[TBL] [Abstract][Full Text] [Related]
2. Preliminary studies of new proteasome inhibitors in the tumor targeting approach: synthesis and in vitro cytotoxicity.
Vivier M; Jarrousse AS; Bouchon B; Galmier MJ; Auzeloux P; Sauzieres J; Madelmont JC
J Med Chem; 2005 Oct; 48(21):6731-40. PubMed ID: 16220988
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.
Dorsey BD; Iqbal M; Chatterjee S; Menta E; Bernardini R; Bernareggi A; Cassarà PG; D'Arasmo G; Ferretti E; De Munari S; Oliva A; Pezzoni G; Allievi C; Strepponi I; Ruggeri B; Ator MA; Williams M; Mallamo JP
J Med Chem; 2008 Feb; 51(4):1068-72. PubMed ID: 18247547
[TBL] [Abstract][Full Text] [Related]
4. Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.
Baldisserotto A; Ferretti V; Destro F; Franceschini C; Marastoni M; Gavioli R; Tomatis R
J Med Chem; 2010 Sep; 53(17):6511-5. PubMed ID: 20687609
[TBL] [Abstract][Full Text] [Related]
5. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.
Tzanopoulou S; Sagnou M; Paravatou-Petsotas M; Gourni E; Loudos G; Xanthopoulos S; Lafkas D; Kiaris H; Varvarigou A; Pirmettis IC; Papadopoulos M; Pelecanou M
J Med Chem; 2010 Jun; 53(12):4633-41. PubMed ID: 20518489
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.
Zhu Y; Yao S; Xu B; Ge Z; Cui J; Cheng T; Li R
Bioorg Med Chem; 2009 Oct; 17(19):6851-61. PubMed ID: 19747832
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
Desbois N; Gardette M; Papon J; Labarre P; Maisonial A; Auzeloux P; Lartigue C; Bouchon B; Debiton E; Blache Y; Chavignon O; Teulade JC; Maublant J; Madelmont JC; Moins N; Chezal JM
Bioorg Med Chem; 2008 Aug; 16(16):7671-90. PubMed ID: 18656367
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary evaluation of the new water-soluble radioactive platinum(IV) complexes.
Garnuszek P; Maurin M; Skierski JS; Koronkiewicz M; Witowska-Jarosz J
J Inorg Biochem; 2004 Mar; 98(3):553-9. PubMed ID: 14987857
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC
Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507
[TBL] [Abstract][Full Text] [Related]
11. Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases.
Mahboobi S; Dove S; Sellmer A; Winkler M; Eichhorn E; Pongratz H; Ciossek T; Baer T; Maier T; Beckers T
J Med Chem; 2009 Apr; 52(8):2265-79. PubMed ID: 19301902
[TBL] [Abstract][Full Text] [Related]
12. Novel organic proteasome inhibitors identified by virtual and in vitro screening.
Basse N; Montes M; Maréchal X; Qin L; Bouvier-Durand M; Genin E; Vidal J; Villoutreix BO; Reboud-Ravaux M
J Med Chem; 2010 Jan; 53(1):509-13. PubMed ID: 19919035
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity.
Marastoni M; Baldisserotto A; Cellini S; Gavioli R; Tomatis R
J Med Chem; 2005 Jul; 48(15):5038-42. PubMed ID: 16033282
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of new retinobenzoic acids.
Khandare RP; Vaze KR; Bhat SV
Chem Biodivers; 2011 May; 8(5):841-9. PubMed ID: 21560232
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of benzamide derivatives of anacardic acid and their cytotoxic activity.
Chandregowda V; Kush A; Reddy GC
Eur J Med Chem; 2009 Jun; 44(6):2711-9. PubMed ID: 19246131
[TBL] [Abstract][Full Text] [Related]
16. Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design.
Woodhead AJ; Angove H; Carr MG; Chessari G; Congreve M; Coyle JE; Cosme J; Graham B; Day PJ; Downham R; Fazal L; Feltell R; Figueroa E; Frederickson M; Lewis J; McMenamin R; Murray CW; O'Brien MA; Parra L; Patel S; Phillips T; Rees DC; Rich S; Smith DM; Trewartha G; Vinkovic M; Williams B; Woolford AJ
J Med Chem; 2010 Aug; 53(16):5956-69. PubMed ID: 20662534
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2,5-diaminobenzamide derivatives as anti-proliferating agents.
Lee SH; Park JW; Hong JE; Park JW; Lee J
Arch Pharm Res; 2009 Jun; 32(6):803-12. PubMed ID: 19557356
[TBL] [Abstract][Full Text] [Related]
18. New aldehyde and vinylsulfone proteasome inhibitors for targeted melanoma therapy.
Vivier M; Rapp M; Galmier MJ; Jarrousse AS; Miot-Noirault E; Leal F; Weber V; Métin J; Sauzière J; Chezal JM; Madelmont JC
Eur J Med Chem; 2011 Nov; 46(11):5705-10. PubMed ID: 21924528
[TBL] [Abstract][Full Text] [Related]
19. Aromatic oligopeptides with chlorambucil moiety--synthesis and biological evaluation.
Bartulewicz D
Acta Pol Pharm; 2005; 62(6):451-5. PubMed ID: 16583984
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.
Zhu Y; Wu G; Zhu X; Ma Y; Zhao X; Li Y; Yuan Y; Yang J; Yu S; Shao F; Lei M
J Med Chem; 2010 Dec; 53(24):8619-26. PubMed ID: 21077681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
